Jan 14, 2026 05:01PM
Jan 14, 2026 05:00PM
Dec 22, 2025 07:06AM
Dec 11, 2025 07:00AM
Dec 11, 2025 07:00AM
Nov 5, 2025 07:00AM
Oct 24, 2025 08:29AM Piper Sandler: 'Biotech Has a Heartbeat: 17 Stocks to Own Through YE25'
Oct 1, 2025 01:20PM
Oct 1, 2025 01:13PM
Aug 12, 2025 07:00AM
Jun 16, 2025 09:00AM
Jan 8, 2025 07:06AM
Jan 8, 2025 07:05AM
Nov 12, 2024 07:00AM Centessa Pharmaceuticals Reports Financial Results for the Third Quarter of 2024 and Provides Business Update
Sep 26, 2024 06:01AM
Sep 26, 2024 06:00AM
Sep 10, 2024 07:00AM
Sep 10, 2024 07:00AM
Aug 27, 2024 08:10AM
Aug 27, 2024 08:00AM
Aug 13, 2024 07:00AM Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the Second Quarter of 2024
May 13, 2024 04:10PM
Apr 22, 2024 07:00AM
Apr 22, 2024 07:00AM
Mar 28, 2024 04:28PM
Feb 26, 2024 07:00AM
Feb 9, 2024 07:00AM
Dec 11, 2023 03:50AM Centessa Pharmaceuticals (CNTA) Reports New Data from Additional 52-Weeks of Continuous Treatment from Third Year (Part 5) of Phase 2a Study of SerpinPC for Hemophilia
Dec 10, 2023 12:05PM
Nov 13, 2023 04:05PM
Nov 2, 2023 09:09AM
Oct 31, 2023 08:00AM
Aug 14, 2023 07:00AM
Jul 10, 2023 08:00AM
May 22, 2023 07:00AM Centessa Pharmaceuticals (CNTA) Receives Fast Track Designation from the U.S. FDA for SerpinPC for Hemophilia B
May 22, 2023 07:00AM
May 12, 2023 07:00AM
Mar 30, 2023 07:06AM
Mar 30, 2023 07:00AM
Mar 30, 2023 07:00AM
Feb 6, 2023 08:00AM
Feb 6, 2023 08:00AM Centessa Pharmaceuticals to Present Additional Data from Open-Label Extension (OLE) of Phase 2a Study of SerpinPC for Hemophilia at the 16th Annual Congress of the European Association for Haemophilia
Jan 26, 2023 09:08AM
Jan 26, 2023 09:08AM
Jan 26, 2023 09:08AM
Jan 16, 2023 09:00PM
Dec 10, 2022 03:30PM
Dec 10, 2022 03:30PM
Nov 10, 2022 07:00AM Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the Third Quarter of 2022
Nov 10, 2022 07:00AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All